Cargando…

Beclomethasone Has Lesser Suppressive Effects on Inflammation and Antibacterial Immunity Than Fluticasone or Budesonide in Experimental Infection Models

Detalles Bibliográficos
Autores principales:	Kamal, Faisal, Glanville, Nicholas, Xia, Wangmingyu, Bakhsoliani, Eteri, Aniscenko, Julia, Bartlett, Nathan W., Edwards, Michael R., Johnston, Sebastian L., Singanayagam, Aran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476496/ https://www.ncbi.nlm.nih.gov/pubmed/32454043 http://dx.doi.org/10.1016/j.chest.2020.05.531

Ejemplares similares

In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices
por: Nave, Ruediger, et al.
Publicado: (2007)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

Budesonide and fluticasone and adrenal suppression
por: Fouda, Mona A, et al.
Publicado: (2012)

Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations
por: Calderazzo, Maria Adelaide, et al.
Publicado: (2019)

Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD
por: Singh, Dave, et al.
Publicado: (2014)

Comparison of the Effects of Beclomethasone Dipropionate and Budesonide in the Treatment of Children with Mild, Persistent Asthma
por: Bukhari, Ibrahim, et al.
Publicado: (2021)

Comparison of Effectiveness between Beclomethasone Dipropionate and Fluticasone Propionate in Treatment of Children with Moderate Asthma
por: Ahmadiafshar, Akefeh, et al.
Publicado: (2010)

Bone Density in Asthmatic Patients Taking Inhaled Corticosteroids: Comparison of Budesonide and Beclomethasone Dipropionate
por: Packe, G E, et al.
Publicado: (1996)

Budesonide and fluticasone propionate differentially affect the airway epithelial barrier
por: Heijink, I. H., et al.
Publicado: (2016)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
por: Belchamber, Kylie BR, et al.
Publicado: (2018)

Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial
por: Farne, Hugo, et al.
Publicado: (2022)

A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD
por: Singanayagam, Aran, et al.
Publicado: (2015)

Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis
por: Ahmet, Alexandra, et al.
Publicado: (2016)

Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate
por: Provost, Karin A., et al.
Publicado: (2019)

Nebulized step-down budesonide vs. fluticasone in infantile asthma: A retrospective cohort study
por: Wu, Zhimin, et al.
Publicado: (2020)

Nebulized step-down budesonide vs. fluticasone in infantile asthma: A retrospective cohort study
por: Wu, Zhimin, et al.
Publicado: (2020)

Efficacy of intranasal fluticasone propionate and budesonide in management of allergic rhinitis—a prospective comparative study
por: Shankari, P. Kiruba, et al.
Publicado: (2021)

Comparison of clinical effects of beclomethasone dipropionate & budesonide in treatment of children with mild persistent asthma: A double-blind, randomized, controlled study
por: Singh, Anju, et al.
Publicado: (2016)

Aerosol Characteristics and Physico-Chemical Compatibility of Combivent(®) (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine
por: Zhang, Rui, et al.
Publicado: (2020)

Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX versus 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and meta-analysis
por: Barberio, Brigida, et al.
Publicado: (2023)

Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management
por: Daley-Yates, Peter, et al.
Publicado: (2023)

Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis
por: Numan, Laith, et al.
Publicado: (2023)

Antiviral immunity is impaired in COPD patients with frequent exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2019)

Adrenal suppression in an asthmatic presenting after change from high dose inhaled fluticasone propionate to inhaled budesonide
por: Abdurahman, Zainab B, et al.
Publicado: (2010)

Correction to: Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management
por: Daley-Yates, Peter, et al.
Publicado: (2023)

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
por: Finney, Lydia J., et al.
Publicado: (2021)

Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease
por: Fahim, Ahmed, et al.
Publicado: (2012)

Efficacy of treatment with montelukast, fluticasone propionate and budesonide liquid suspension for the prevention of recurrent asthma paroxysms in children with wheezing disorders
por: Ding, Bo, et al.
Publicado: (2019)

Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies
por: Lodise, Thomas P, et al.
Publicado: (2020)

Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life
por: Price, David B, et al.
Publicado: (2007)

Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
por: Yu, Iseul, et al.
Publicado: (2022)

Real-life effectiveness of fluticasone furoate/vilanterol after switching from fluticasone/salmeterol or budesonide/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for Real Asthma Control Study (RERACS study)
por: Shimizu, Yasuo, et al.
Publicado: (2020)

Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease
por: Mallia, Patrick, et al.
Publicado: (2018)

A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation
por: Ringdal, N., et al.
Publicado: (1996)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
por: Perrone, Valentina, et al.
Publicado: (2016)

Budesonide, fluticasone propionate, and azithromycin do not modulate the membrane vesicle release by THP-1 macrophages and respiratory pathogens during macrophage infection
por: Volgers, Charlotte, et al.
Publicado: (2017)

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
por: Choi, Jae-Hwa, et al.
Publicado: (2021)

Reply to: “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Letter]
por: Barnes, Neil C, et al.
Publicado: (2021)

New Pharmacologic Perspectives in Pneumology: Beclomethasone-Formoterol Extrafine
por: Paggiaro, Pierluigi
Publicado: (2009)

On-demand intermittent beclomethasone is effective for mild asthma in Brazil
por: Camargos, Paulo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eepfqvbtlmn57vu4pfd5efba9t